International Congress Amsterdam 2015


The emergence of drug-resistant tuberculosis in Europe: no cure possible?

Symposium
Chairs: Martin J. Boeree (Nijmegen, Netherlands), Masoud Dara (Copenhagen, Denmark)
Aims: To gain insights into the mechanism of bacterial drug resistance, learn about the molecular epidemiology of M. tuberculosis and the biological mechanisms that facilitate bacterial transmission, become alert about the latest official drug resistance surveillance data, become aware of the latest treatment outcome data, learn about the latest research findings regarding optimisation of the management of M/XDR-TB, become aware of the key aspects of the consensus statement for the management of M/XDR-TB and understand the WHO strategy for TB control and elimination.
Target audience: Clinicians, microbiologists, epidemiologists, specialist nurses, and scientists interested in tuberculosis and other respiratory infections.
Patient's testimonial
Gabriela Spita (Iasi, Romania)
WebcastSlide presentationMultimedia files
WebcastSlide presentationMultimedia files
Molecular epidemiology of M. tuberculosis drug resistance in Europe
Dick van Soolingen (Nijmegen, Netherlands)
WebcastSlide presentationMultimedia files
WebcastSlide presentationMultimedia files
Drug-resistant tuberculosis in the European Union and European economic area
Marieke van der Werf (Stockholm, Sweden)
WebcastSlide presentationMultimedia files
WebcastSlide presentationMultimedia files
Management of patients with M/XDR-tuberculosis in Europe
Christoph Lange (Borstel, Germany)
WebcastSlide presentationMultimedia files
WebcastSlide presentationMultimedia files